Similar articles for PMID: 30656409

Year	Number of Results
1973	1
1995	1
1997	3
1998	3
1999	2
2000	1
2001	3
2002	9
2003	7
2004	12
2005	8
2006	6
2007	4
2008	11
2009	5
2010	4
2011	16
2012	16
2013	13
2014	11
2015	12
2016	10
2017	10
2018	12
2019	13
2020	16
2021	10
2022	15
2023	7
2024	0

1

Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.

Zhang Y, Zhang Y, Zhang L. Zhang Y, et al. J Cancer Res Clin Oncol. 2019 Feb;145(2):281-291. doi: 10.1007/s00432-019-02840-3. Epub 2019 Jan 17. J Cancer Res Clin Oncol. 2019. PMID: 30656409 Free PMC article. Review.

2

NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study.

Bolli M, Schultz-Thater E, Zajac P, Guller U, Feder C, Sanguedolce F, Carafa V, Terracciano L, Hudolin T, Spagnoli GC, Tornillo L. Bolli M, et al. Int J Cancer. 2005 Jul 20;115(6):960-6. doi: 10.1002/ijc.20953. Int J Cancer. 2005. PMID: 15751033 Free article.

3

Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.

Suda T, Tsunoda T, Daigo Y, Nakamura Y, Tahara H. Suda T, et al. Cancer Sci. 2007 Nov;98(11):1803-8. doi: 10.1111/j.1349-7006.2007.00603.x. Cancer Sci. 2007. PMID: 17784873 Free article.

4

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.

Mashino K, Sadanaga N, Tanaka F, Yamaguchi H, Nagashima H, Inoue H, Sugimachi K, Mori M. Mashino K, et al. Br J Cancer. 2001 Sep 1;85(5):713-20. doi: 10.1054/bjoc.2001.1974. Br J Cancer. 2001. PMID: 11531257 Free PMC article.

5

Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.

Akcakanat A, Kanda T, Tanabe T, Komukai S, Yajima K, Nakagawa S, Ohashi M, Hatakeyama K. Akcakanat A, et al. Int J Cancer. 2006 Jan 1;118(1):123-8. doi: 10.1002/ijc.21219. Int J Cancer. 2006. PMID: 16003736 Free article.

6

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. Odunsi K, et al. Cancer Res. 2003 Sep 15;63(18):6076-83. Cancer Res. 2003. PMID: 14522938

7

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.

Gjerstorff MF, Pøhl M, Olsen KE, Ditzel HJ. Gjerstorff MF, et al. BMC Cancer. 2013 Oct 8;13:466. doi: 10.1186/1471-2407-13-466. BMC Cancer. 2013. PMID: 24103781 Free PMC article.

8

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

Vaughan HA, Svobodova S, Macgregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen YT, Stockert E, St Clair F, Old LJ, Cebon J. Vaughan HA, et al. Clin Cancer Res. 2004 Dec 15;10(24):8396-404. doi: 10.1158/1078-0432.CCR-04-0809. Clin Cancer Res. 2004. PMID: 15623618

9

[Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma].

Zhang WM, Xiao G, Zhang M, Guo AL, Dong Y, Wen JM. Zhang WM, et al. Zhonghua Bing Li Xue Za Zhi. 2005 Apr;34(4):202-5. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16091172 Chinese.

10

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.

Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, Decock J. Thomas R, et al. Front Immunol. 2018 May 1;9:947. doi: 10.3389/fimmu.2018.00947. eCollection 2018. Front Immunol. 2018. PMID: 29770138 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

222 results

Results by year